Dihydroartemisinin inhibits mutant KRAS to potentiate regorafenib plus anti-PD-1 in KRAS-mutant colorectal cancer liver metastases
- DOI
- 10.1038/s41419-026-09042-z
- Published
- 2026-07-06
- Container
- Cell Death & Disease
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s41419-026-09042-z,
title = {Dihydroartemisinin inhibits mutant KRAS to potentiate regorafenib plus anti-PD-1 in KRAS-mutant colorectal cancer liver metastases},
author = {Ning Huang and Liming Wang and Hongming Deng and Chenyang Nan and Zhenbang Ye and Changchun Zhou and Jiajun Zhang and Ruoyu Zhang and Ke Xu and Jianxiong Wu and Rui Liu and Mei Liu},
year = {2026},
journal = {Cell Death \& Disease},
doi = {10.1038/s41419-026-09042-z},
url = {https://doi.org/10.1038/s41419-026-09042-z}
}RIS
TY - JOUR TI - Dihydroartemisinin inhibits mutant KRAS to potentiate regorafenib plus anti-PD-1 in KRAS-mutant colorectal cancer liver metastases AU - Ning Huang AU - Liming Wang AU - Hongming Deng AU - Chenyang Nan AU - Zhenbang Ye AU - Changchun Zhou AU - Jiajun Zhang AU - Ruoyu Zhang AU - Ke Xu AU - Jianxiong Wu AU - Rui Liu AU - Mei Liu PY - 2026 JO - Cell Death & Disease DO - 10.1038/s41419-026-09042-z UR - https://doi.org/10.1038/s41419-026-09042-z ER -
APA
Huang, N., Wang, L., Deng, H., Nan, C., Ye, Z., Zhou, C., Zhang, J., Zhang, R., Xu, K., Wu, J., Liu, R., & Liu, M. (2026). Dihydroartemisinin inhibits mutant KRAS to potentiate regorafenib plus anti-PD-1 in KRAS-mutant colorectal cancer liver metastases. Cell Death & Disease. https://doi.org/10.1038/s41419-026-09042-z
Source records
- crossref · retrieved 2026-09-26T08:23:46.190Z